Enhanced Implantable Drug Delivery System for Opioid Overdose Treatment
Legal Citation
Summary of the Inventive Concept
The present inventive concept discloses an improved implantable drug delivery system that addresses the limitations of existing single-use devices, providing a sustained release of medication over an extended period, customizable treatment options, and enhanced safety features for opioid overdose treatment.
Background and Problem Solved
The original patent disclosed a single-use implantable drug delivery device for treating opioid overdoses. However, this device has limitations, including the inability to provide sustained release of medication, limited customization options, and potential overheating issues. The present inventive concept addresses these limitations by introducing a system of multiple devices, customizable treatment options, and safety features to enhance the effectiveness and safety of opioid overdose treatment.
Detailed Description of the Inventive Concept
The enhanced implantable drug delivery system comprises a plurality of devices, each with a housing, reservoir, and temporary seal. The devices are designed to be triggered in a staggered manner, providing a sustained release of medication over an extended period. The system also includes a wearable device for detecting physiological reactions to an opioid overdose, which communicates with the implantable device to trigger the delivery of medication. Additionally, the device includes a cooling mechanism to prevent overheating and customizable settings based on an individual's physiological response to an opioid overdose.
Novelty and Inventive Step
The present inventive concept introduces a novel system of multiple devices, customizable treatment options, and safety features that overcome the limitations of existing single-use devices. The staggered triggering of devices, wearable detection device, and cooling mechanism are new and non-obvious features that enhance the effectiveness and safety of opioid overdose treatment.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include varying the number and configuration of devices, using different types of sensors or detection mechanisms, or incorporating additional safety features such as automatic shutdown or alert systems. Variations could also include adapting the system for use with different types of medications or treating other medical conditions.
Potential Commercial Applications and Market
The enhanced implantable drug delivery system has significant commercial potential in the medical device industry, particularly in the treatment of opioid overdoses. The system's customizable treatment options, sustained release of medication, and enhanced safety features make it an attractive solution for healthcare providers, patients, and caregivers. The market for opioid overdose treatment devices is growing rapidly, and this inventive concept is well-positioned to capture a significant share of this market.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M5/14276 |
| A | A61 | A61B5/4839 |
| A | A61 | A61B5/4845 |
| A | A61 | A61B5/4848 |
| A | A61 | A61K9/0024 |
| A | A61 | A61K9/0097 |
| A | A61 | A61M5/44 |
| A | A61 | A61M31/002 |
| A | A61 | A61M37/0069 |
| A | A61 | A61B5/01 |
| A | A61 | A61F2250/0068 |
| A | A61 | A61K31/485 |
Original Patent Information
| Patent Number | US 11,857,758 |
|---|---|
| Title | Drug delivery device and method |
| Assignee(s) | Purdue Research Foundation |